Kerkhoff Andrew D, West Nora S, Del Mar Castro Maria, Branigan David, Christopher Devasahayam J, Denkinger Claudia M, Nhung Nguyen Viet, Theron Grant, Worodria William, Yu Charles, Muyoyeta Monde, Cattamanchi Adithya
Division of HIV, Infectious Diseases and Global Medicine Zuckerberg San Francisco General Hospital and Trauma Center, University of California San Francisco, San Francisco, CA, USA.
Center for Tuberculosis, University of California San Francisco, San Francisco, CA, USA.
BMC Glob Public Health. 2023;1(1). doi: 10.1186/s44263-023-00027-0. Epub 2023 Nov 21.
To reach the millions of people with tuberculosis (TB) undiagnosed each year, there is an important need to provide people-centered screening and testing services. Despite people-centered care being a key pillar of the WHO END-TB Strategy, there have been few attempts to formally characterize and integrate the preferences of people affected by TB - including those who have increased exposure to TB, limited access to services, and/or are at increased risk for TB - into new tools and strategies to improve screening and diagnosis. This perspective emphasizes the importance of preference research among people affected by TB, provides an overview of qualitative preference exploration and quantitative preference elicitation research methods, and outlines how preferences can be applied to improve the acceptability, accessibility, and appropriateness of TB screening and testing services via four key opportunities. These include the following: (1) Defining the most preferred features of novel screening, triage, and diagnostic tools, (2) exploring and prioritizing setting-specific barriers and facilitators to screening and testing, (3) understanding what features of community- and facility-based strategies for improving TB detection and treatment are most valued, and (4) identifying the most relevant and resonant communication strategies to increase individual- and community-level awareness and demand. Preference research studies and translation of their findings into policy/guidance and operationalization have enormous potential to close the existing gaps in detection in high burden settings by enhancing the people-centeredness and reach of screening and diagnostic services to people affected by TB who are currently being missed and left behind.
为了覆盖每年数百万未被诊断出患有结核病的人群,迫切需要提供以患者为中心的筛查和检测服务。尽管以患者为中心的护理是世界卫生组织终止结核病战略的关键支柱之一,但几乎没有人尝试正式描述和整合结核病患者的偏好——包括那些结核病暴露风险增加、获得服务机会有限和/或结核病发病风险增加的人群——并将其纳入新的工具和战略中,以改善筛查和诊断。本文强调了在结核病患者中开展偏好研究的重要性,概述了定性偏好探索和定量偏好引出研究方法,并概述了如何通过四个关键机会将偏好应用于提高结核病筛查和检测服务的可接受性、可及性和适宜性。这些机会包括:(1)定义新型筛查、分诊和诊断工具最受欢迎的特征;(2)探索并确定特定环境下筛查和检测的障碍及促进因素的优先级;(3)了解社区和医疗机构层面提高结核病检测和治疗的策略中最受重视的特征;(4)确定最相关且能引起共鸣的沟通策略,以提高个人和社区层面的意识及需求。偏好研究及其结果转化为政策/指南和实际操作,具有巨大潜力,可通过增强以患者为中心的理念以及扩大筛查和诊断服务的覆盖范围,覆盖目前被遗漏和忽视的结核病患者,从而缩小高负担地区在检测方面的现有差距。